Benjamin Halladay - Dec 17, 2024 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
Chief Financial Officer
Signature
/s/ Sheldon L. Koenig, by power of attorney
Stock symbol
ESPR
Transactions as of
Dec 17, 2024
Transactions value $
-$7,866
Form type
4
Date filed
12/18/2024, 04:14 PM
Previous filing
Mar 15, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$7.87K -3.25K -1.33% $2.42 241K Dec 17, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on vested shares of restricted stock units.